These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6099734)
21. Enalapril for severe congestive heart failure. A double-blind study. Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995 [TBL] [Abstract][Full Text] [Related]
22. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604 [TBL] [Abstract][Full Text] [Related]
23. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Sharpe DN; Murphy J; Coxon R; Hannan SF Circulation; 1984 Aug; 70(2):271-8. PubMed ID: 6329547 [TBL] [Abstract][Full Text] [Related]
24. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients. Packer M; Medina N; Yushak M; Lee WH Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697 [TBL] [Abstract][Full Text] [Related]
25. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure]. Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945 [TBL] [Abstract][Full Text] [Related]
26. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. Franciosa JA; Wilen MM; Jordan RA J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088 [TBL] [Abstract][Full Text] [Related]
27. [Short- and long-term effects of enalapril on the left ventricular function in patients with congestive heart insufficiency]. Traina M; Rotolo A; Trapani R; Messina L; Candela B; Mercurio G; Raineri A Cardiologia; 1990 Jan; 35(1):55-60. PubMed ID: 2376053 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). Fouad FM; Tarazi RC; Bravo EL; Textor SC Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515 [TBL] [Abstract][Full Text] [Related]
29. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940 [TBL] [Abstract][Full Text] [Related]
30. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084 [TBL] [Abstract][Full Text] [Related]
31. The clinical pharmacology of enalapril. Gomez HJ; Cirillo VJ; Jones KH J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610 [TBL] [Abstract][Full Text] [Related]
32. Clinical studies of enalapril treatment for patients with severe congestive heart failure. Sato T; Takeshi M; Yamamoto A Jpn Circ J; 1992 Jan; 56(1):35-45. PubMed ID: 1538575 [TBL] [Abstract][Full Text] [Related]